RGEN 8-K 2026-09-08

REPLIGEN CORP (RGEN) 8-K dated 2026-09-08 — accession 0001193125-26-385380. This URL is the filing, not the RGEN hub.

REPLIGEN CORP (RGEN) is a medical instruments & supplies company listed on NASDAQ.

REPLIGEN CORP filed a 8-K on 2026-09-08. Accession 0001193125-26-385380.

Cached items: 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported RGEN revenue for 2026-06-30 was $204.1M. Net income was $5.0M. Revenue was up 5.1% from 2026-03-31 to 2026-06-30. RGEN currently screens at market cap $7.43B and trailing P/E 143.1.

Not investment advice. The RGEN SEC hub lists recent forms. The stock page is the research view.